Conversely, when PERK activation is persistent, as it occurs in PD and other neurodegenerative diseases, the UPR pathway reverts its adaptive response to a proapoptotic response mainly by promoting the expression of the transcriptional regulator C/EBP homologous protein (CHOP) [81]. This evidence concerns the gene EIF2AK3 and neurodegenerative disease.